Osteoporosis Market Research Reports & Industry Analysis

Browse All Osteoporosis Market Research Reports
Pages: « Last  1    Displaying 1 to 13 (of 13 records)
Latest Report
Title
Published Date
Price
 
Post Menopausal Osteoporosis Pipeline Review, H1 2012
By- Global Markets Direct

Post Menopausal Osteoporosis Pipeline Review, H1 2012 Summary Global Markets Directs, 'Post Menopausal Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Post Menopausal Osteoporosis therapeutic pipeline. This report provides...
 April 2012
 $ 500
 
Osteoporosis Pipeline Review, H1 2012
By- Global Markets Direct

Osteoporosis Pipeline Review, H1 2012 Summary Global Markets Directs, 'Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Osteoporosis therapeutic pipeline. This report provides information on the therapeutic development for ...
 February 2012
 $ 500
 
Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012
By- GlobalData

Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012" provides data on the Post Menopausal Osteoporosis clinical tri...
 February 2012
 $ 1000
 
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
By- Transparency Market Research

In 2009, the global Osteoporosis drug market was worth USD 6.8 billion, with Bisphosphonate class of drugs leading the market. In the overall Bisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate (Aclasta/Zometa; Novartis) accounted...
 January 2012
 $ 2395
 
China Osteoporosis Market Analysis and Forecast, 2007 - 2015
By- Transparency Market Research

The Chinese Osteoporosis drug market is expected to grow at a CAGR of 14.4% from 2007 to 2015. Increased prevalence of Osteoporosis among Chinese female population is the principal growth driver of the Osteoporosis drug market. The other key gr...
 January 2012
 $ 1500
 
Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Osteoporosis Market
By- GBI Research

GBI Research, a leading business intelligence provider, has released its latest research “Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopau...
 January 2012
 $ 3500
 
Global Osteoporosis Market & Drugs Analysis 2010 - 2015
By- Renub Research

Osteoporosis Market Overview Osteoporosis is often called the ""silent disease"" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to bone fragility a...
 September 2011
 $ 1050
 
Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
By- GlobalData

Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Mar...
 July 2011
 $ 2000
 
Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011
By- GlobalData

Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011 Summary GlobalData's clinical trial report, Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011" provides data on the Post Menopausal Osteoporosis clinical tri...
 June 2011
 $ 1000
 
Osteoporosis Global Clinical Trials Review, Q1, 2011
By- GlobalData

Osteoporosis Global Clinical Trials Review, Q1, 2011 Summary GlobalData's clinical trial report, Osteoporosis Global Clinical Trials Review, Q1, 2011" provides data on the Osteoporosis clinical trial scenario. This report provides elemental info...
 April 2011
 $ 1000
 
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
By- GBI Research

GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth an...
 October 2010
 $ 3500
 
Osteoporosis - Pipeline Assessment and Market Forecasts to 2017
By- GlobalData

Osteoporosis - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, Osteoporosis - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source...
 September 2010
 $ 2000
 
Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
By- GBI Research

Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets Summary GBI Researchs report, Women's Health Therapeutics Market to 2016 - High Un...
 August 2010
 $ 3500
Pages: « Last  1    Displaying 1 to 13 (of 13 records)